These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 18242386)
1. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo. Okamoto A; Shirakawa T; Bito T; Shigemura K; Hamada K; Gotoh A; Fujisawa M; Kawabata M Urology; 2008 Jan; 71(1):156-60. PubMed ID: 18242386 [TBL] [Abstract][Full Text] [Related]
2. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines. Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244 [TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo. Shigemura K; Shirakawa T; Wada Y; Kamidono S; Fujisawa M; Gotoh A Urology; 2005 Dec; 66(6):1239-44. PubMed ID: 16360450 [TBL] [Abstract][Full Text] [Related]
4. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells. Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520 [TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor. Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736 [TBL] [Abstract][Full Text] [Related]
6. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602 [TBL] [Abstract][Full Text] [Related]
7. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity. Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837 [TBL] [Abstract][Full Text] [Related]
11. Differential accumulation of hypericin in spheroids composed of T-24 transitional cell carcinoma cells expressing different levels of E-cadherin. Huygens A; Crnolatac I; Develter J; Van Cleynenbreugel B; Van der Kwast T; de Witte PA J Urol; 2008 May; 179(5):2014-9. PubMed ID: 18355860 [TBL] [Abstract][Full Text] [Related]
12. [Effects of selective cyclooxygenase-2 inhibitor on proliferation and apoptosis of human bladder cancer cell line T24]. Zhang J; Xu ZQ; Hu Q; Qiu XW; Wang ZR Ai Zheng; 2007 Apr; 26(4):377-81. PubMed ID: 17430655 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells. Qin J; Yuan J; Li L; Liu H; Qin R; Qin W; Chen B; Wang H; Wu K Biomed Pharmacother; 2009 Mar; 63(3):241-8. PubMed ID: 18617357 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes. Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251 [TBL] [Abstract][Full Text] [Related]
15. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. Shariat SF; Matsumoto K; Kim J; Ayala GE; Zhou JH; Jian W; Benedict WF; Lerner S J Urol; 2003 Sep; 170(3):985-9. PubMed ID: 12913755 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines. Adhim Z; Matsuoka T; Bito T; Shigemura K; Lee KM; Kawabata M; Fujisawa M; Nibu K; Shirakawa T Br J Cancer; 2011 Jul; 105(3):393-402. PubMed ID: 21750550 [TBL] [Abstract][Full Text] [Related]
17. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas]. Zhan J; Tang XD Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218 [TBL] [Abstract][Full Text] [Related]
18. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ. Bindels EM; Vermey M; van den Beemd R; Dinjens WN; Van Der Kwast TH Cancer Res; 2000 Jan; 60(1):177-83. PubMed ID: 10646871 [TBL] [Abstract][Full Text] [Related]
19. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells. Lampiasi N; FoderĂ D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822 [TBL] [Abstract][Full Text] [Related]
20. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]